Page last updated: 2024-08-23

sq-11725 and Experimental Neoplasms

sq-11725 has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arregi, A; Azpiroz, A; Beitia, G; Garmendia, L; Vegas, O1
Avraham, R; Bartal, I; Ben-Eliyahu, S; Benish, M; Inbar, S; Rosenne, E1
Fishbein, L; Jackson, CD1

Reviews

1 review(s) available for sq-11725 and Experimental Neoplasms

ArticleYear
A toxicological review of beta-adrenergic blockers.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1986, Volume: 6, Issue:3

    Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol

1986

Other Studies

2 other study(ies) available for sq-11725 and Experimental Neoplasms

ArticleYear
Effects of antalarmin and nadolol on the relationship between social stress and pulmonary metastasis development in male OF1 mice.
    Behavioural brain research, 2009, Dec-14, Volume: 205, Issue:1

    Topics: Adrenergic beta-Antagonists; Aggression; Animals; Central Nervous System Agents; Corticosterone; Interferon-gamma; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Nadolol; Neoplasms, Experimental; Pyrimidines; Pyrroles; Random Allocation; Receptors, Corticotropin-Releasing Hormone; Social Behavior; Stress, Psychological

2009
Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression.
    Brain, behavior, and immunity, 2010, Volume: 24, Issue:6

    Topics: Adjuvants, Immunologic; Adrenergic beta-Antagonists; Animals; Catecholamines; Cell Line, Tumor; Cyclooxygenase Inhibitors; Disease Progression; Flow Cytometry; Hormone Antagonists; Immune Tolerance; Indomethacin; Interleukin-12; Killer Cells, Natural; Laparotomy; Lung Neoplasms; Nadolol; Neoplasms, Experimental; Poly I-C; Postoperative Complications; Prostaglandin Antagonists; Rats; Rats, Inbred F344; Survival

2010